AiCure
Founded 2010 Β· 39 employees on LinkedIn Β· 4 known investors
AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement. The platform serves pharmaceutical companies, clinical trial operators, and healthcare organizations seeking objective insights into medication compliance without wearables or invasive hardware.
Founders & leadership
Investors Β· 4
Founder mafia
2 people who came through AiCure went on to found or lead other companies.
Non-dilutive funding Β· 5 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $997.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $227.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $137.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $273.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does AiCure do?
- AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement. The platform serves pharmaceutical companies, clinical trial operators, and healthcare organizations seeking objective insights into medication compliance without wearables or invasive hardware.
- Who are AiCure's investors?
- AiCure's investors include VIVE VC, Accelmed Partners, Palisades Growth Capital, Tribeca Venture Partners.